Bio

Chris began his professional life as an academic, and for ten years was a Professor at London Business School. Chris has also worked for a number of global management consultancy strategy boutiques in both Europe and North America. His route into marcoms was to create a joint venture with CDP while at Coopers & Lybrand, for the purpose of new business. He was so intrigued by CDP that he became their Business Development Director. For 10 years Chris was with McCann-Erickson in Asia; he was both Vice-Chairman of their operations in Tokyo and Chief Strategy Officer for Asia, in which one of his roles was WorldGroup marcoms service development, beyond traditional advertising, across Asia. Chris then spent some 6 years leading Grey Group Japan during which time they prospered and extended their specialist communications capabilities through the acquisition of Grey Healthcare, as well as also being responsible for their strategic development across Asia. He was the Asian representative on IBM’s global advisory for mobile. In October 2008, the University of Tokyo made Chris a Professor in their Global Centre of Excellence to foster global best in class collaboration between business and academic initiatives. He is a central member of the initiative to create a new regulatory and multi-disciplinary environment for healthcare and well-being, such policy change can accelerate innovation and branded commercial success across Asia. His work centres on translational aspects of scientific discovery across pharma; life-sciences; nano- and bio-technology, as well as The University of Tokyo hospital.